Arkolith/Insider Trading/PCVX/Form 4

Cowan Elvia

SVP, Finance & CAOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Apr 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$180K
Net Open-Market Flow
-$180K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 7, 2026Option exercise(M)3K$25.92$78K32K
Apr 7, 2026Sell(S)3K$60.00$180K29K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 7, 2026Option exercise(M)3K—$093K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001960048-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML